JP2001354553A5 - - Google Patents

Download PDF

Info

Publication number
JP2001354553A5
JP2001354553A5 JP2001095221A JP2001095221A JP2001354553A5 JP 2001354553 A5 JP2001354553 A5 JP 2001354553A5 JP 2001095221 A JP2001095221 A JP 2001095221A JP 2001095221 A JP2001095221 A JP 2001095221A JP 2001354553 A5 JP2001354553 A5 JP 2001354553A5
Authority
JP
Japan
Prior art keywords
acid
aspartyl
gin
malic
tartaric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001095221A
Other languages
English (en)
Japanese (ja)
Other versions
JP3754625B2 (ja
JP2001354553A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2001095221A priority Critical patent/JP3754625B2/ja
Priority claimed from JP2001095221A external-priority patent/JP3754625B2/ja
Publication of JP2001354553A publication Critical patent/JP2001354553A/ja
Publication of JP2001354553A5 publication Critical patent/JP2001354553A5/ja
Application granted granted Critical
Publication of JP3754625B2 publication Critical patent/JP3754625B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001095221A 2000-04-12 2001-03-29 安定化されたユビデカレノン組成物およびユビデカレノン組成物の安定化方法 Expired - Lifetime JP3754625B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001095221A JP3754625B2 (ja) 2000-04-12 2001-03-29 安定化されたユビデカレノン組成物およびユビデカレノン組成物の安定化方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-110384 2000-04-12
JP2000110384 2000-04-12
JP2001095221A JP3754625B2 (ja) 2000-04-12 2001-03-29 安定化されたユビデカレノン組成物およびユビデカレノン組成物の安定化方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2004300880A Division JP2005053923A (ja) 2000-04-12 2004-10-15 安定化されたユビデカレノン組成物およびユビデカレノン組成物の安定化方法

Publications (3)

Publication Number Publication Date
JP2001354553A JP2001354553A (ja) 2001-12-25
JP2001354553A5 true JP2001354553A5 (enExample) 2004-12-09
JP3754625B2 JP3754625B2 (ja) 2006-03-15

Family

ID=26589927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001095221A Expired - Lifetime JP3754625B2 (ja) 2000-04-12 2001-03-29 安定化されたユビデカレノン組成物およびユビデカレノン組成物の安定化方法

Country Status (1)

Country Link
JP (1) JP3754625B2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3406911B1 (ja) 2002-08-28 2003-05-19 アサヒ飲料株式会社 コエンザイムｑ１０を含む飲料及びその製造方法
JP5034226B2 (ja) * 2004-11-30 2012-09-26 大正製薬株式会社 配合成分が安定化された固形製剤
KR100869444B1 (ko) * 2007-07-11 2008-11-18 주식회사 중외제약 유비데카레논을 함유하는 다층정 비타민 복합제제
WO2009061105A2 (en) * 2007-11-09 2009-05-14 Cj Cheiljedang Corporation Stabilized preparation containing coenzyme q10 and process for preparation thereof
TWI478709B (zh) 2008-02-19 2015-04-01 Earnest Medicine Co Ltd A useful oral or enteral composition for the recovery of bodily functions
JP6459206B2 (ja) * 2014-04-25 2019-01-30 ユーハ味覚糖株式会社 高吸収型ユビキノール製剤
JP6146129B2 (ja) * 2013-05-20 2017-06-14 ユーハ味覚糖株式会社 還元型コエンザイムｑ１０含有グミキャンディの製造方法

Similar Documents

Publication Publication Date Title
WO2001058412A3 (de) Extrakte von rückständen aus der weinherstellung
WO2004096798A3 (fr) Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique
CA2396159A1 (en) Novel substituted benzimidazole dosage forms and method of using same
MX249034B (es) Amidinas de tiofeno novedosas, composiciones de las mismas, y metodos para tratar enfermedades y condiciones mediadas por el complemento.
CA2436540A1 (en) Pharmaceutical compositions based on anticholinergics and corticosteroids
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
ATE253912T1 (de) Verwendung von nikotinergen acetylcholinrezeptor- agonisten zur herstellung eines medikaments zur behandlung von keratoconjuctivitis sicca
JP2003518501A5 (enExample)
PL363153A1 (en) Chemically-modified antimicrobial peptides, compositions and methods of production and use
WO2001079458A3 (en) Polypeptides having haloperoxidase activity
JP2002533216A5 (enExample)
WO2004083369A3 (fr) Composition de fixation tissulaire
WO2003099110A3 (en) Herbs and herbal combinations useful for the treatment of microbial infections
HK1049115A1 (zh) 治療過敏性失調的成分和方法
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
PL366401A1 (en) Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
WO2005018605A3 (en) Novel formulation of ropinirole
EP1195166A3 (en) Use of a vasopressin antagonist such as conivaptan in the manufacture of a medicament for treating pulmonary hypertension
WO2003026563A3 (en) Conjugated anti-psychotic drugs and uses thereof
EP2783697A3 (en) VIP Fragments and Methods of Use
WO2003039453A3 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
AU2003251198A1 (en) Composition comprising the extract of cistanche deserticola y.c. ma showing enhancing activity of the neurite outgrowth and neurotrophic effects
WO2007134118A3 (en) Protein based composition and methods of using same
ATE307561T1 (de) Verwendung von spezifischen fettstoffen zur modifizierung der physico-chemischen eigenschaften der haut und/oder der schleimhaut als mittel zur verhinderung oder reduzierung der adhäsion von mikro-organismen darauf
WO2001052855A8 (en) Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone